Chronic bronchitis overview

Revision as of 13:12, 22 September 2016 by Mehdi Pahlavani (talk | contribs)
Jump to navigation Jump to search

Chronic Obstructive Pulmonary Disease Page

Bronchitis Main Page

Chronic bronchitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic bronchitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

Echocardiography or Ultrasound

Treatment

Medical Therapy

Lung Transplant

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic bronchitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic bronchitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic bronchitis overview

CDC on Chronic bronchitis overview

Chronic bronchitis overview in the news

Blogs on Chronic bronchitis overview

Directions to Hospitals Treating Chronic bronchitis

Risk calculators and risk factors for Chronic bronchitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Bronchitis is an inflammation of the bronchi (medium-size airways) in the lungs. Acute bronchitis is usually caused by viruses or bacteria and may last several days or weeks. Chronic bronchitis is not necessarily caused by infection and is generally part of a syndrome called chronic obstructive pulmonary disease (COPD); it is defined clinically as a persistent cough that produces sputum (phlegm) and mucus, for at least three months in two consecutive years.

Historical Perspective

Pathophysiology

  • Hyperplasia and hypertrophy of the goblet cells (mucous gland) of the airway are the common pathologic features of chronic bronchitis. Chronic inflammation due to lymphocyte infiltration seen on microscopy[3].
  • On microscopic histopathological analysis there is infiltration of the airway walls with inflammatory cells, particularly CD8+ T-lymphocytes and neutrophils[4].
  • Inflammation is followed by scarring and remodeling that thickens the walls resulting in narrowing of the small airways

Causes

  • Chronic bronchitis as a subtype of COPD is caused by multiple environmental and genetic factors. Smoking is the leading cause of chronic bronchitis. Other causes include: air pollutants, occupational exposures to dusts and coal and auto-immune diseases[5][6][7][8].

Differentiating Chronic bronchitis from other Diseases

Chronic bronchitis must be differentiated from other causes of chronic cough and dyspnea which include:congestive heart failure, chronic asthma, bronchiectasis, and bronchiolitis obliterans[9][10].

Epidemiology and Demographics

  • COPD occurs in 34 out of 1000 greater than 65 years old[11] or possibly approximately 25 million people if undiagnosed cases are included.[12].
  • COPD is the third cause of death in the U.S[13].
  • Hispanics were less likely to report COPD than non-Hispanic whites and blacks (4.0% compared with 6.3% and 6.1%, respectively)[14].
  • Chronic bronchitis mortality rates are higher among whites than among blacks or persons of all other races.
  • Women were more likely to report COPD than men (6.7% compared with 5.2%)[14][15].
  • Age adjusted death rates of men has decreased between 1999 till 2014 but this rate was stable among women.

Risk Factors

Common risk factors in the development of chronic bronchitis include cigarette smoking, air pollution, genetic factors, increasing age, male gender, allergy, and repeated airway infections[16][17][18][17][19].

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

Ultrasound

Other Imaging Studies

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

References

  1. terms(2016)https://lunginstitute.com/blog/history-of-chronic-bronchitis/accessed on September,13 2016
  2. Klippe HJ, Kirsten D (2009). "[200 years of bronchitis--from 1808 to 2008]". Pneumologie (in German). 63 (4): 228–30. doi:10.1055/s-0028-1119572. PMID 19343614.
  3. Hogg JC (2004). "Pathophysiology of airflow limitation in chronic obstructive pulmonary disease". Lancet. 364 (9435): 709–21. doi:10.1016/S0140-6736(04)16900-6. PMID 15325838.
  4. Baraldo S, Turato G, Badin C, Bazzan E, Beghé B, Zuin R, Calabrese F, Casoni G, Maestrelli P, Papi A, Fabbri LM, Saetta M (2004). "Neutrophilic infiltration within the airway smooth muscle in patients with COPD". Thorax. 59 (4): 308–12. PMC 1763819. PMID 15047950.
  5. MedicineNet.com - COPD causes
  6. Young RP, Hopkins RJ, Christmas T, Black PN, Metcalf P, Gamble GD (2009). "COPD prevalence is increased in lung cancer, independent of age, sex and smoking history". Eur. Respir. J. 34 (2): 380–6. doi:10.1183/09031936.00144208. PMID 19196816. Unknown parameter |month= ignored (help)
  7. Devereux, Graham (2006). "Definition, epidemiology, and risk factors". BMJ. 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. PMC 1459603. PMID 16690673. Unknown parameter |month= ignored (help)
  8. Kennedy SM, Chambers R, Du W, Dimich-Ward H (2007). "Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?". Proceedings of the American Thoracic Society. 4 (8): 692–4. doi:10.1513/pats.200707-094SD. PMID 18073405. Unknown parameter |month= ignored (help)
  9. Busse WW (2011). "Asthma diagnosis and treatment: filling in the information gaps". J. Allergy Clin. Immunol. 128 (4): 740–50. doi:10.1016/j.jaci.2011.08.014. PMID 21875745.
  10. Prina E, Ranzani OT, Torres A (2015). "Community-acquired pneumonia". Lancet. 386 (9998): 1097–108. doi:10.1016/S0140-6736(15)60733-4. PMID 26277247.
  11. wrongdiagnosis.com > Prevalence and Incidence of COPD Retrieved on Mars 14, 2010
  12. MORBIDITY & MORTALITY: 2009 CHART BOOK ON CARDIOVASCULAR, LUNG, AND BLOOD DISEASES National Heart, Lung, and Blood Institute
  13. Kenneth D. Kochanek, M.A.; Jiaquan Xu, M.D.; Sherry L. Murphy, B.S.; Arialdi M. Minin˜o, M.P.H.; and Hsiang-Ching Kung, Ph.D., Division of Vital Statistics, Deaths: Final Data for 2009, 2011, 60,National Vital Statistics Reports, http://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_03.pdf
  14. 14.0 14.1 Morbidity and Mortality Weekly Report (MMWR).(2011).https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm Accessed on September 19,2016
  15. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD (2004). "The nature of small-airway obstruction in chronic obstructive pulmonary disease". N. Engl. J. Med. 350 (26): 2645–53. doi:10.1056/NEJMoa032158. PMID 15215480.
  16. PIERCE JA, HOCOTT JB, EBERT RV (1961). "The collagen and elastin content of the lung in emphysema". Ann. Intern. Med. 55: 210–22. PMID 13735539.
  17. 17.0 17.1 Raherison C, Girodet PO (2009). "Epidemiology of COPD". Eur Respir Rev. 18 (114): 213–21. doi:10.1183/09059180.00003609. PMID 20956146.
  18. Mehta GR, Mohammed R, Sarfraz S, Khan T, Ahmed K, Villareal M, Martinez D, Iskander J, Mohammed R (2016). "Chronic obstructive pulmonary disease: A guide for the primary care physician". Dis Mon. 62 (6): 164–87. doi:10.1016/j.disamonth.2016.03.002. PMID 27087562.
  19. Jeffery PK (2000). "Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture". Chest. 117 (5 Suppl 1): 251S–60S. PMID 10843939.

Template:WH Template:WS